Ponoi Management, LLC, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 225,103 shares at $11.36 ($2.5M) on 2022-05-10, disclosed to the SEC on 2022-05-11.
Open-market purchase of $2.5M NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.79 | 2,745 | $30K | 1.2% |
| 2 | $10.79 | 80,430 | $868K | 35.2% |
| 3 | $10.79 | 80,430 | $868K | 35.2% |
| 4 | $11.36 | 1,032 | $12K | 0.5% |
| 5 | $11.36 | 30,233 | $343K | 13.9% |
| 6 | $11.36 | 30,233 |
| $343K |
| 13.9% |
| Total | $10.95 avg | 225,103 | $2.5M | 100% |
| Filing → |
| NGM | BUY | 2022-05-26 | $1.6M | — | Filing → |
| RAPT | BUY | 2022-05-25 | $324K | — | Filing → |
| NGM | BUY | 2020-03-23 | $6.8M | — | Filing → |